Structure Therapeutics (GPCR) Other financing activities (2022 - 2026)

Structure Therapeutics' Other financing activities history runs 5 years deep, the most recent figure standing at $869000.0 for Q1 2026.

• In Q1 2026, Other financing activities fell 9.95% year-over-year to $869000.0; the TTM figure through Mar 2026 stood at $4.4 million (up 114.58% YoY), while the FY2025 annual figure was $4.5 million, up 144.07% from the prior year.
• Other financing activities for Q1 2026 stood at $869000.0, down from $4.1 million in the prior quarter.
• The five-year high for Other financing activities was $172.3 million in Q1 2023, with the low at -$172.1 million in Q2 2023.
• The 5-year median for Other financing activities is $616500.0 (2024), against an average of $21.9 million.
• The sharpest annual moves came in 2023 and 2025: Other financing activities jumped 593300.0% in 2023, then sank 234.51% in 2025.
• Structure Therapeutics' Other financing activities stood at $29000.0 in 2022, then jumped by 440258.62% to $127.7 million in 2023, then tumbled by 99.82% to $224000.0 in 2024, then surged by 1708.48% to $4.1 million in 2025, then slumped by 78.55% to $869000.0 in 2026.
• Business Quant data shows GPCR's Other financing activities at $869000.0 in Q1 2026, $4.1 million in Q4 2025, and -$534000.0 in Q3 2025.